[水一帖]关于IARC的一类致癌物清单和一张图还有一点个人之见

List of Classifications IARC Monographs on the Identification of Carcinogenic Hazards to Humans

CAS No.  Agent  Group  Volume  Year  Additional information
  Aloe vera, whole leaf extract  2B  108  2016  
  Clonorchis sinensis (infection with)  1  61, 100B  2012  
  Fusarium graminearum, F. culmorum, and F. crookwellense, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X)  3  Sup 7, 56  1993  
  Fusarium sporotrichioides, toxins derived from (T-2 toxin)  3  56  1993  
  Helicobacter pylori (infection with)  1  61, 100B  2012  
  Microcystis extracts  3  94  2010  
  Opisthorchis felineus (infection with)  3  61  1994  
  Opisthorchis viverrini (infection with)  1  61, 100B  2012  
  Schistosoma haematobium (infection with)  1  61, 100B  2012  
  Schistosoma japonicum (infection with)  2B  61  1994  
  Schistosoma mansoni (infection with)  3  61  1994  
  Acheson process, occupational exposure associated with  1  111  2017  
  Acid mists, strong inorganic  1  54, 100F  2012  
  Acrylic fibres  3  19, Sup 7  1987  
  Acrylonitrile-butadiene-styrene copolymers  3  19, Sup 7  1987  
  Alcoholic beverages  1  44, 96, 100E  2012  
  Alpha particles (see Radionuclides)        
  Aluminium production  1  34, Sup 7, 92, 100F  2012  
  Anaesthetics, volatile  3  11, Sup 7  1987  
  Androgenic (anabolic) steroids  2A  Sup 7  1987  
  Areca nut  1  85, 100E  2012  
  Arecoline  2B  128  In prep.  
  Art glass, glass containers and pressed ware (manufacture of)  2A  58  1993  
  Auramine production  1  Sup 7, 99, 100F  2012  
  BK polyomavirus (BKV)  2B  104  2014  
  Benzidine, dyes metabolized to  1  99, 100F  2012  NB Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
  Beta particles (see Radionuclides)        
  Betel quid with tobacco  1  Sup 7, 85, 100E  2012  
  Betel quid without tobacco  1  Sup 7, 85, 100E  2012  
  Biomass fuel (primarily wood), indoor emissions from household combustion of  2A  95  2010  
  Bisulfites  3  54  1992  
  Bitumens, occupational exposure to hard bitumens and their emissions during mastic asphalt work  2B  103  2013  
  Boot and shoe manufacture and repair (see Leather dust, Benzene)    25, Sup 7  1987  
  Bracken fern  2B  40, Sup 7  1987  
  Calcium carbide production  3  92  2010  
  Carbon electrode manufacture  2A  92  2010  
  Carpentry and joinery  2B  25, Sup 7  1987  
  Ceramic implants  3  74  1999  
  Chimney sweeping (see Soot)    92  2010  
  Chlorinated drinking-water  3  52  1991  
  Chlorinated paraffins of average carbon chain length C12 and average degree of chlorination approximately 60%  2B  48  1990  
  Chlorophenols (see Polychlorophenols)        
  Chlorophenoxy herbicides  2B  41, Sup 7  1987  
  Coal dust  3  68  1997  
  Coal gasification  1  Sup 7, 92, 100F  2012  
  Coal, indoor emissions from household combustion of  1  95, 100E  2012  
  Coffee, drinking  3  51, 116  2018 online  NB There is "evidence suggesting lack of carcinogenicity" in humans of coffee drinking for cancers of the pancreas, liver, female breast, uterine endometrium, and prostate. Inverse associations with coffee drinking have been observed with cancers of the liver and uterine endometrium.
  Coke production  1  Sup 7, 92, 100F  2012  
  Continuous glass filament (see Glass filament)        
  Dental materials  3  74  1999  
  Diesel engine exhaust (see Engine exhaust, diesel)        
  Diesel fuel, marine  2B  45  1989  NB Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
  Diesel fuels, distillate (light)  3  45  1989  
  Dry cleaning (occupational exposures in)  2B  63  1995  
  Dyes metabolized to benzidine (see Benzidine, dyes metabolized to)        
  Electric fields, extremely low-frequency  3  80  2002  
  Electric fields, static  3  80  2002  
  Engine exhaust, diesel  1  46, 105  2014  
  Engine exhaust, gasoline  2B  46, 105  2014  
  Epstein-Barr virus  1  70, 100B  2012  
  Estrogen therapy, postmenopausal  1  72, 100A  2012  
  Estrogen-progestogen menopausal therapy (combined)  1  72, 91, 100A  2012  
  Estrogen-progestogen oral contraceptives (combined)  1  72, 91, 100A  2012  NB There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary
  Firefighter (occupational exposure as a)  2B  98  2010  
  Fission products, including strontium-90  1  100D  2012  
  Flat-glass and specialty glass (manufacture of)  3  58  1993  
  Fluorescent lighting  3  55  1992  
  Fluoro-edenite fibrous amphibole  1  111  2017  
  Foreign? bodies (see Ceramic implants, Dental materials, Implanted foreign bodies, Metallic implants, Organic polymeric materials, Orthopaedic implants, Polymeric implants, Silicone breast implants)        
  Frying, emissions from high-temperature  2A  95  2010  
  Fuel oils, distillate (light)  3  45  1989  
  Fuel oils, residual (heavy)  2B  45  1989  
  Furniture and cabinet making (see Wood dust)    25, Sup 7  1987  
  Gamma-Radiation (see X- and Gamma-Radiation)        
  Gasoline  2B  45  1989  NB Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
  Gasoline engine exhaust (see Engine exhaust, gasoline)        
  Glass filament, continuous  3  43, 81  2002  
  Goldenseal root powder  2B  108  2016  
  Haematite mining (underground)  1  1, Sup 7, 100D  2012  
  Hair colouring products (personal use of)  3  57, 99  2010  
  Hairdresser or barber (occupational exposure as a)  2A  57, 99  2010  
  Hepatitis B virus (chronic infection with)  1  59, 100B  2012  
  Hepatitis C virus (chronic infection with)  1  59, 100B  2012  
  Hepatitis D virus  3  59  1994  
  Hexachlorocyclohexanes  2B  20, Sup 7  1987  
  High-temperature frying (see Frying)        
  Household combustion of biomass fuel (see Biomass fuel, indoor emissions from household combustion of)        
  Household combustion of coal (see Coal, indoor emissions from household combustion)        
  Human T-cell lymphotropic virus type I  1  67, 100B  2012  
  Human T-cell lymphotropic virus type II  3  67  1996  
  Human herpesvirus type 4 (see Epstein-Barr virus)        
  Human herpesvirus type 8 (see Kaposi sarcoma herpesvirus)        
  Human immunodeficiency virus type 1 (infection with)  1  67, 100B  2012  
  Human immunodeficiency virus type 2 (infection with)  2B  67  1996  
  Human papillomavirus genus beta (except types 5 and 8) and genus gamma  3  90, 100B  2012  
  Human papillomavirus type 68  2A  100B  2012  
  Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59  1  64, 90, 100B  2012  NB The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer
  Human papillomavirus types 26, 53, 66, 67, 70, 73, 82  2B  100B  2012  
  Human papillomavirus types 30, 34, 69, 85, 97  2B  100B  2012  NB Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1
  Human papillomavirus types 5 and 8 (in patients with epidermodysplasia verruciformis)  2B  100B  2012  
  Human papillomavirus types 6 and 11  3  90, 100B  2012  
  Hypochlorite salts  3  52  1991  
  Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based, and titanium-based alloys, stainless steel and depleted uranium  3  74  1999  
  Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium, and 7% iron  2B  74  1999  
  Insulation glass wool  3  43, 81  2002  
  Involuntary smoking (see Tobacco smoke, second-hand)        
  Ionizing radiation (all types)  1  100D  2012  
  Iron and steel founding (occupational exposure during)  1  34, Sup 7, 100F  2012  
  Isopropyl alcohol manufacture using strong acids  1  Sup 7, 100F  2012  
  Isopropyl oils  3  15, Sup 7, 71  1999  
  JC polyomavirus (JCV)  2B  104  2014  
  Jet fuel  3  45  1989  
  Kaposi sarcoma herpesvirus  1  70, 100B  2012  
  Lead compounds, inorganic  2A  Sup 7, 87  2006  
  Lead compounds, organic  3  23, Sup 7, 87  2006  NB Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead
  Leather dust  1  100C  2012  
  Leather goods manufacture  3  25, Sup 7  1987  
  Leather tanning and processing  3  25, Sup 7  1987  
  Lumber and sawmill industries (including logging)  3  25, Sup 7  1987  
  MOPP and other combined chemotherapy including alkylating agents  1  Sup 7, 100A  2012  
  Madder root (Rubia tinctorum)  3  82  2002  
  Magenta production  1  Sup 7, 57, 99, 100F  2012  
  Magnetic fields, extremely low-frequency  2B  80  2002  
  Magnetic fields, static  3  80  2002  
  Malaria (caused by infection with Plasmodium falciparum in holoendemic areas)  2A  104  2014  
  Mate, hot (see Very hot beverages)        
  Mate, not very hot (drinking)  3  51, 116  2018 online  
  Merkel cell polyomavirus (MCV)  2A  104  2014  
  Metabisulfites  3  54  1992  
  Metallic implants prepared as thin smooth films  2B  74  1999  
  Methylmercury compounds  2B  58  1993  NB Evaluated as a group
  Mineral oils, highly-refined  3  33, Sup 7  1987  
  Mineral oils, untreated or mildly treated  1  33, Sup 7, 100F  2012  
  Modacrylic fibres  3  19, Sup 7  1987  
  Neutron radiation  1  75, 100D  2012  NB Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data
  Nickel compounds  1  Sup 7, 49, 100C  2012  
  Nickel refining (see Nickel compounds)    11  1976  
  Night shift work  2A  98, 124  2020 online  NB Volume 98 evaluated shiftwork that involves circadian disruption
  Nitrate or nitrite (ingested) under conditions that result in endogenous nitrosation  2A  94  2010  
  Non-arsenical insecticides (occupational exposures in spraying and application of)  2A  53  1991  
  Oestrogen (see Estrogen)        
  Opium consumption  1  126  In prep.  
  Oral contraceptives, combined estrogen-progestogen (see Estrogen-progestogen oral contraceptives)        
  Organic polymeric materials  3  74  1999  
  Orthopaedic implants of complex composition and cardiac pacemakers  3  74  1999  
  Outdoor air pollution  1  109  2016  
  Outdoor air pollution, particulate matter in  1  109  2016  
  Paint manufacture (occupational exposure in)  3  47  1989  
  Painter (occupational exposure as a)  1  47, 98, 100F  2012  
  Particulate matter in outdoor air pollution (see Outdoor air pollution, particulate matter in)        
  Paving and roofing with coal-tar pitch (see Coal-tar pitch)    35, Sup 7, 92, 100F  2010  
  Petroleum refining (occupational exposures in)  2A  45  1989  
  Petroleum solvents  3  47  1989  
  Phenacetin, analgesic mixtures containing  1  Sup 7, 100A  2012  
  Pickled vegetables (traditional Asian)  2B  56  1993  
  Polychlorinated biphenyls, dioxin-like, with a Toxicity Equivalency Factor (TEF) according to WHO (PCBs 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, 189)  1  107  2016  NB Overall evaluation upgraded to Group 1 with strong supporting evidence from other relevant data
  Polychlorinated dibenzo-para-dioxins (other than 2,3,7,8-tetrachlorodibenzo-para-dioxin)  3  69  1997  
  Polychlorinated dibenzofurans (see 2,3,4,7,8-Pentachlorodibenzofuran)  3  69  1997  
  Polychlorophenols and their sodium salts (mixed exposures) (see Pentachlorophenol; 2,4,6-Trichlorophenol)  2B  53, 71  1999  
  Polymeric implant prepared as thin smooth films (with the exception of poly-glycolic acid)  2B  74  1999  
  Printing inks  3  65  1996  
  Printing processes (occupational exposures in)  2B  65  1996  
  Processed meat (consumption of)  1  114  2018  
  Proflavine salts  3  24, Sup 7  1987  
  Progestins  2B  Sup 7  1987  
  Progestogen-only contraceptives  2B  72  1999  
  Pulp and paper manufacture  3  25, Sup 7  1987  
  Radiofrequency electromagnetic fields  2B  102  2013  
  Radioiodines, including iodine-131  1  78, 100D  2012  
  Radionuclides, alpha-particle-emitting, internally deposited  1  78, 100D  2012  NB Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents
  Radionuclides, beta-particle-emitting, internally deposited  1  78, 100D  2012  NB Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents
  Red meat (consumption of)  2A  114  2018  
  Refractory ceramic fibres  2B  43, 81  2002  
  Rock (stone) wool  3  43, 81  2002  
  Rubber manufacturing industry  1  28, Sup 7, 100F  2012  
  SV40 polyomavirus  3  104  2014  
  Salted fish, Chinese-style  1  56, 100E  2012  
  Silicone breast implants  3  74  1999  
  Slag wool  3  43, 81  2002  
  Solar radiation  1  55, 100D  2012  
  Soot (as found in occupational exposure of chimney sweeps)  1  35, Sup 7, 92, 100F  2012  
  Special-purpose fibres such as E-glass and '475' glass fibres  2B  81  2002  
  Sulfites  3  54  1992  
  Sunlamps and sunbeds (see Ultraviolet-emitting tanning devices)        
  Surgical implants (see Ceramic implants, Dental materials, Implanted foreign bodies, Metallic implants, Organic polymeric materials, Orthopaedic implants, Polymeric implants, Silicone breast implants)        
  Tea  3  51  1991  
  Tetrakis(hydroxymethyl)phosphonium salts  3  48, 71  1999  
  Textile manufacturing industry (work in)  2B  48  1990  
  Tobacco smoke, second-hand  1  83, 100E  2012  
  Tobacco smoking  1  83, 100E  2012  
  Tobacco, smokeless  1  Sup 7, 89, 100E  2012  
  Toxins derived from certain Fusarium species (see Fusarium)        
  Ultraviolet radiation (wavelengths 100-400 nm, encompassing UVA, UVB, and UVC)  1  55, 100D*, 118#  2018 online  *Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders; #Volume 118 concluded that ultraviolet emissions from welding are carcinogenic to humans (Group 1). There is sufficient evidence in humans for the carcinogenicity of ultraviolet emissions from welding)
  Ultraviolet-emitting tanning devices  1  100D  2012  
  Urethane (see Ethyl carbamate)        
  Very hot beverages at above 65 °C (drinking)  2A  116  2018 online  
  Welding fumes  1  49, 118  2018 online  
  Wood dust  1  62, 100C  2012  
  Wood smoke (see Biomass fuel, indoor emissions from household combustion)        
  X- and Gamma-Radiation  1  75, 100D  2012  
100-00-5  4-Chloronitrobenzene  2B  65, 123  2020 online  
100-17-4  para-Nitroanisole  2B  123  2020 online  
100-40-3  4-Vinylcyclohexene  2B  Sup 7, 60  1994  
100-41-4  Ethylbenzene  2B  77  2000  
100-42-5  Styrene  2A  60, 82, 121  2019  
100-75-4  N-Nitrosopiperidine  2B  17, Sup 7  1987  
10026-24-1  Cobalt sulfate and other soluble cobalt(II) salts  2B  86  2006  
10043-66-0  Iodine-131 (see Radioiodines)        
10043-92-2  Radon-222 and its decay products  1  43, 78, 100D  2012  
10048-13-2  Sterigmatocystin  2B  10, Sup 7  1987  
10048-32-5  Parasorbic acid  3  10, Sup 7  1987  
10098-97-2  Strontium-90 (see Fission products)        
101-14-4  4,4'-Methylenebis(2-chloroaniline) (MOCA)  1  Sup 7, 57, 99, 100F  2012  NB Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
101-21-3  Chloropropham  3  12, Sup 7  1987  
101-25-7  Dinitrosopentamethylenetetramine  3  11, Sup 7  1987  
101-61-1  Michler’s base [4,4?-methylenebis(N,N-dimethyl)?benzenamine]  2B  27, Sup 7, 99  2010  
101-68-8  4,4'-Methylenediphenyl diisocyanate  3  19, Sup 7, 71  1999  
101-77-9  4,4'-Methylenedianiline  2B  39, Sup 7  1987  
101-80-4  4,4'-Diaminodiphenyl ether  2B  29, Sup 7  1987  
101-90-6  Diglycidyl resorcinol ether  2B  36, Sup 7, 71  1999  
101043-37-2  Microcystin-LR  2B  94  2010  
102-50-1  meta-Cresidine  3  27, Sup 7  1987  
102-71-6  Triethanolamine  3  77  2000  
103-03-7  Phenicarbazide  3  12, Sup 7  1987  
103-11-7  2-Ethylhexyl acrylate  2B  60, 122  2019  
103-23-1  Di(2-ethylhexyl) adipate  3  Sup 7, 77  2000  
103-33-3  Azobenzene  3  8, Sup 7  1987  
103-90-2  Acetaminophen (see Paracetamol)        
103-90-2  Paracetamol (Acetaminophen)  3  50, 73  1999  
10380-28-6  Copper 8-hydroxyquinoline  3  15, Sup 7  1987  
104-94-9  para-Anisidine  3  27, Sup 7  1987  
105-11-3  para-Benzoquinone dioxime  3  29, Sup 7, 71  1999  
105-55-5  N,N'-Diethylthiourea  3  79  2001  
105-60-2  Caprolactam  3  39, Sup 7, 71  1999  Moved to Group 3 following 2019 update to the IARC Monographs Preamble
105-74-8  Lauroyl peroxide  3  36, Sup 7, 71  1999  
10540-29-1  Tamoxifen  1  66, 100A  2012  NB There is also conclusive evidence that tamoxifen reduces the risk of contralateral breast cancer in breast cancer patients
105650-23-5  PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine)  2B  56  1993  
105735-71-5  3,7-Dinitrofluoranthene  2B  46, 65, 105  2014  
10595-95-6  N-Nitrosomethylethylamine  2B  17, Sup 7  1987  
10599-90-3  Chloramine  3  84  2004  
106-46-7  para-Dichlorobenzene  2B  Sup 7, 73  1999  
106-47-8  para-Chloroaniline  2B  57  1993  
106-50-3  para-Phenylenediamine  3  16, Sup 7  1987  
106-51-4  para-Quinone  3  15, Sup 7, 71  1999  
106-87-6  4-Vinylcyclohexene diepoxide  2B  Sup 7, 60  1994  
106-88-7  1,2-Epoxybutane  2B  47, 71  1999  NB Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
106-89-8  Epichlorohydrin  2A  11, Sup 7, 71  1999  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
106-91-2  Glycidyl methacrylate  2A  125  2020 online  
106-93-4  Ethylene dibromide  2A  15, Sup 7, 71  1999  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
106-94-5  1-Bromopropane  2B  115  2018  
106-99-0  1,3-Butadiene  1  Sup 7, 54, 71, 97, 100F  2012  
107-02-8  Acrolein  2A  63 (corr. 65), Sup 7, 128  In prep.  
107-05-1  Allyl chloride  3  36, Sup 7, 71, 125  2020 online  
107-06-2  1,2-Dichloroethane  2B  20, Sup 7, 71  1999  
107-13-1  Acrylonitrile  2B  71  1999  
107-14-2  Chloroacetonitrile  3  52, 71  1999  
107-30-2  Chloromethyl methyl ether (see Bis(chloromethyl)ether; chloromethyl methyl ether)        
1071-83-6  Glyphosate  2A  112  2017  
1072-52-2  2-(1-Aziridinyl)ethanol  3  9, Sup 7  1987  
108-05-4  Vinyl acetate  2B  Sup 7, 63  1995  
108-10-1  Methyl isobutyl ketone  2B  101  2013  
108-30-5  Succinic anhydride  3  15, Sup 7  1987  
108-45-2  meta-Phenylenediamine  3  16, Sup 7  1987  
108-46-3  Resorcinol  3  15, Sup 7, 71  1999  
108-60-1  Bis(2-chloro-1-methylethyl)ether  3  41, Sup 7, 71  1999  
108-78-1  Melamine  2B  Sup 7, 73, 119  2019  
108-88-3  Toluene  3  47, 71  1999  
108-94-1  Cyclohexanone  3  47, 71  1999  
108-95-2  Phenol  3  47, 71  1999  
108-99-6  β-Picoline  3  122  2019  
109-70-6  1-Bromo-3-chloropropane  2B  125  2020 online  
109-99-9  Tetrahydrofuran  2B  119  2019  
110-00-9  Furan  2B  63  1995  
110-57-6  trans-1,4-Dichlorobutene  3  15, Sup 7, 71  1999  
110-86-1  Pyridine  2B  77, 119  2019  
110-91-8  Morpholine  3  47, 71  1999  
11056-06-7  Bleomycins  2B  26, Sup 7  1987  NB Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
111-42-2  Diethanolamine  2B  77, 101  2013  
111-44-4  Bis(2-chloroethyl)ether  3  9, Sup 7, 71  1999  
111-76-2  2-Butoxyethanol  3  88  2006  
111025-46-8  Pioglitazone  2A  108  2016  
111189-32-3  Naphtho[1,2-b]fluoranthene  3  92  2010  
1116-54-7  N-Nitrosodiethanolamine  2B  17, Sup 7, 77  2000  
1120-71-4  1,3-Propane sultone  2A  4, Sup 7, 71, 110  2017  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
1143-38-0  Dithranol  3  13; Sup 7  1987  
115-02-6  Azaserine  2B  10, Sup 7  1987  
115-07-1  Propylene  3  Sup 7, 60  1994  
115-28-6  Chlorendic acid  2B  48  1990  
115-32-2  Dicofol  3  30, Sup 7  1987  
115-96-8  Tris(2-chloroethyl) phosphate  3  48, 71  1999  
116-06-3  Aldicarb  3  53  1991  
116-14-3  Tetrafluoroethylene  2A  19, Sup 7, 71, 110  2017  NB Overall evaluation upgraded to Group 2A on the basis of sufficient evidence in experimental animals with a striking and atypical pattern of tumours
1163-19-5  Decabromodiphenyl oxide  3  48, 71  1999  
116355-83-0  Fusarium moniliforme, toxins derived from (fumonisin B1, fumonisin B2, and fusarin C)  2B  56  1993  
116355-83-0  Fumonisin B1  2B  82  2002  
117-10-2  Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone)  2B  50  1990  
117-39-5  Quercetin  3  Sup 7, 73  1999  
117-79-3  2-Aminoanthraquinone  3  27, Sup 7  1987  
117-81-7  Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl) phthalate)        
117-81-7  Di(2-ethylhexyl)phthalate  2B  Sup 7, 77, 101  2013  
118-74-1  Hexachlorobenzene  2B  Sup 7, 79  2001  
118-92-3  Anthranilic acid  3  16, Sup 7  1987  
118-96-7  2,4,6-Trinitrotoluene  3  65  1996  
118399-22-7  Nodularins  3  94  2010  
119-34-6  4-Amino-2-nitrophenol  3  16, Sup 7  1987  
119-61-9  Benzophenone  2B  101  2013  
119-90-4  3,3'-Dimethoxybenzidine (ortho-Dianisidine)  2B  4, Sup 7  1987  
119-93-7  3,3'-Dimethylbenzidine (ortho-Tolidine)  2B  1, Sup 7  1987  
120-12-7  Anthracene  3  92, Sup 7  2010  
120-58-1  Isosafrole  3  10, Sup 7  1987  
120-71-8  para-Cresidine  2B  27, Sup 7  1987  
120-80-9  Catechol  2B  15, Sup 7, 71  1999  
12001-79-5  Vitamin K substances  3  76  2000  
12070-12-1, 7440-48-4  Tungsten carbide with cobalt metal (see Cobalt metal with tungsten carbide)        
121-14-2  2,4-Dinitrotoluene  2B  65  1996  
121-66-4  2-Amino-5-nitrothiazole  3  31, Sup 7  1987  
121-69-7  N,N-Dimethylaniline  3  57  1993  
121-75-5  Malathion  2A  30, Sup 7, 112  2017  
121-88-0  2-Amino-5-nitrophenol  3  57  1993  
12122-67-7  Zineb  3  12, Sup 7  1987  
12174-11-7  Attapulgite (see Palygorskite)        
12174-11-7  Palygorskite (Attapulgite) (long fibres, > 5 micrometres)  2B  68  1997  
12174-11-7  Palygorskite (Attapulgite)(short fibres, < 5 micrometres)  3  68  1997  
12192-57-3  Aurothioglucose  3  13, Sup 7  1987  
122-34-9  Simazine  3  53, 73  1999  
122-42-9  Propham  3  12, Sup 7  1987  
122-60-1  Phenyl glycidyl ether  2B  47, 71  1999  
122320-73-4  Rosiglitazone  3  108  2016  
123-31-9  Hydroquinone  3  15, Sup 7, 71  1999  
123-33-1  Maleic hydrazide  3  4, Sup 7  1987  
123-35-3  β-Myrcene  2B  119  2019  
123-91-1  1,4-Dioxane  2B  11, Sup 7, 71  1999  
124-48-1  Chlorodibromomethane  3  52, 71  1999  
124-58-3  Methylarsonic acid  2B  100C  2012  
124-58-3  Monomethylarsonic acid (see Methylarsonic acid)        
12427-38-2  Maneb  3  12, Sup 7  1987  
125-33-7  Primidone  2B  108  2016  
126-07-8  Griseofulvin  2B  Sup 7, 79  2001  
126-72-7  Tris(2,3-dibromopropyl) phosphate  2A  20, Sup 7, 71  1999  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
126-85-2  Nitrogen mustard N-oxide  2B  9, Sup 7  1987  
126-99-8  Chloroprene  2B  Sup 7, 71  1999  
12663-46-6  Cyclochlorotine  3  10, Sup 7  1987  
127-07-1  Hydroxyurea  3  76  2000  
127-18-4  Tetrachloroethylene (Perchloroethylene)  2A  Sup 7, 63, 106  2014  
127-19-5  N,N-Dimethylacetamide  2B  123  2020 online  
127-69-5  Sulfafurazole (Sulfisoxazole)  3  24, Sup 7  1987  
128-37-0  Butylated hydroxytoluene (BHT)  3  40, Sup 7  1987  
128-66-5  Vat Yellow 4  3  48  1990  
129-00-0  Pyrene  3  Sup 7, 92  2010  
129-15-7  2-Methyl-1-nitroanthraquinone (uncertain purity)  2B  27, Sup 7  1987  
129-17-9  Blue VRS  3  16, Sup 7  1987  
129-20-4  Oxyphenbutazone  3  13, Sup 7  1987  
129-43-1  1-Hydroxyanthraquinone  2B  82  2002  
129-73-7  Leucomalachite green (see also Malachite green)  2B  129  In prep.  
13010-47-4  1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)  2A  26, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
1303-00-0  Gallium arsenide (see Arsenic and inorganic arsenic compounds)    86, 100C  2012  
13045-94-8  Medphalan  3  9, Sup 7  1987  
1309-37-1  Ferric oxide  3  1, Sup 7  1987  
1309-64-4  Antimony trioxide  2B  47  1989  
131-79-3  Yellow OB  3  8, Sup 7  1987  
1313-27-5  Molybdenum trioxide  2B  118  2018 online  
1314-62-1  Vanadium pentoxide  2B  86  2006  
1317-60-8  Haematite  3  1, Sup 7  1987  
1318-02-1  Zeolites other than erionite (clinoptilolite, phillipsite,mordenite, non-fibrous Japanese zeolite, synthetic zeolites)  3  68  1997  
132-27-4  Sodium ortho-phenylphenate  2B  Sup 7, 73  1999  
132-65-0  Dibenzothiophene  3  103  2013  
13233-32-4  Radium-224 and its decay products  1  78, 100D  2012  
13256-22-9  N-Nitrososarcosine  2B  17, Sup 7  1987  
13292-46-1  Rifampicin  3  24, Sup 7  1987  
133-06-2  Captan  3  30, Sup 7  1987  
1330-20-7  Xylenes  3  47, 71  1999  
1332-21-4, 12172-73-5, 12001-29-5, 12001-28-4  Asbestos (all forms, including actinolite, amosite, anthophyllite, chrysotile, crocidolite, tremolite)  1  14, Sup 7, 100C  2012  NB Mineral substances (e.g. talc or vermiculite) that contain asbestos should also be regarded as carcinogenic to humans *The presence of an asterisk indicates that the registration is for a substance which CAS does not treat in its regular CA index
1333-86-4  Carbon black  2B  Sup 7, 65, 93  2010  
1336-36-3  Polychlorinated biphenyls  1  18, Sup 7, 107  2016  
1338-16-5  Iron sorbitol-citric acid complex  3  2, Sup 7  1987  
134-29-2  ortho-Anisidine hydrochloride (see also ortho-Anisidine)  2A  127  In prep.  
134-32-7  1-Naphthylamine  3  4, Sup 7  1987  
1345-04-6  Antimony trisulfide  3  47  1989  
13463-67-7  Titanium dioxide  2B  47, 93  2010  
13483-18-6  1,2-Bis(chloromethoxy)ethane  3  15; Sup 7, 71  1999  
135-20-6  Cupferron  2B  127  In prep.  
135-88-6  N-Phenyl-2-naphthylamine  3  16, Sup 7  1987  
136-40-3  Phenazopyridine hydrochloride  2B  24, Sup 7  1987  
137-17-7  2,4,5-Trimethylaniline  3  27, Sup 7  1987  
137-26-8  Thiram  3  Sup 7, 53  1991  
137-30-4  Ziram  3  Sup 7, 53  1991  
138-59-0  Shikimic acid  3  40, Sup 7  1987  
139-05-9  Cyclamates (sodium cyclamate)  3  Sup 7, 73  1999  
139-13-9  Nitrilotriacetic acid and its salts  2B  48, 73  1999  NB Evaluated as a group
139-65-1  4,4'-Thiodianiline  2B  27, Sup 7  1987  
139-94-6  Nithiazide  3  31, Sup 7  1987  
13909-09-6  1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) (see Semustine)        
13909-09-6  Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, Methyl-CCNU]  1  Sup 7, 100A  2012  
13982-63-3  Radium-226 and its decay products  1  78, 100D  2012  
13983-17-0  Wollastonite  3  Sup 7, 68  1997  
140-11-4  Benzyl acetate  3  40, Sup 7, 71  1999  
140-56-7  para-Dimethylaminoazobenzenediazo sodium sulfonate  3  8, Sup 7  1987  
140-57-8  Aramite?  2B  5, Sup 7  1987  
140-88-5  Ethyl acrylate  2B  39, Sup 7, 71, 122  2019  
1401-55-4  Tannic acid and tannins  3  10, Sup 7  1987  
1402-68-2  Aflatoxins  1  Sup 7, 56, 82, 100F  2012  
14047-09-7  3,3′,4,4′-Tetrachloroazobenzene  2A  117  2019  NB Overall evaluation upgraded to Group 2A
141-32-2  n-Butyl acrylate  3  39, Sup 7, 71  1999  
141-37-7  3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexanecarboxylate  3  11, Sup 7, 71  1999  
141-90-2  Thiouracil  2B  Sup 7, 79  2001  
142-04-1  Aniline hydrochloride (see also Aniline)  2A  127  In prep.  
142-83-6  2,4-Hexadienal  2B  101  2013  
143-50-0  Chlordecone (Kepone)  2B  20, Sup 7  1987  
143-67-9  Vinblastine sulfate  3  26, Sup 7  1987  
144-34-3  Methyl selenac  3  12, Sup 7  1987  
14484-64-1  Ferbam  3  12, Sup 7  1987  
14596-37-3  Phosphorus-32, as phosphate  1  78, 100D  2012  
1464-53-5  1,2:3,4-Diepoxybutane (see Monographs on 1,3-Butadiene)    11, Sup 7  1987  
148-18-5  Sodium diethyldithiocarbamate  3  12, Sup 7  1987  
148-24-3  8-Hydroxyquinoline  3  13, Sup 7  1987  
148-82-3  Melphalan  1  9, Sup 7, 100A  2012  
14807-96-6  Talc containing asbestiform fibres (see Asbestos)    42, Sup 7  1987  
14807-96-6  Talc not containing asbestos or asbestiform fibres  3  42, Sup 7, 93  2010  
14807-96-6  Talc-based body powder (perineal use of)  2B  93  2010  
14808-60-7  Silica dust, crystalline, in the form of quartz or cristobalite  1  Sup 7, 68, 100C  2012  
149-29-1  Patulin  3  40, Sup 7  1987  
149-30-4  2-Mercaptobenzothiazole  2A  115  2018  
14901-08-7  Cycasin  2B  10, Sup 7  1987  
150-13-0  para-Aminobenzoic acid  3  16, Sup 7  1987  
150-68-5  Monuron  3  Sup 7, 53  1991  
150-69-6  Dulcin  3  12, Sup 7  1987  
15086-94-9  Eosin  3  15, Sup 7  1987  
151-56-4  Aziridine  2B  9, Sup 7, 71  1999  NB Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
15262-20-1  Radium-228 and its decay products  1  78, 100D  2012  
154-93-8  Bischloroethyl nitrosourea (BCNU)  2A  26, Sup 7  1987  
15501-74-3  Sepiolite  3  Sup 7, 68  1997  
15503-86-3  Isatidine  3  10, Sup 7  1987  
156-10-5  para-Nitrosodiphenylamine  3  27, Sup 7  1987  
156-51-4  Phenelzine sulfate  3  24, Sup 7  1987  
15625-89-5  Trimethylolpropane triacrylate, technical grade  2B  122  2019  
15663-27-1  Cisplatin  2A  26, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
15721-02-5  2,2',5,5'-Tetrachlorobenzidine  3  27, Sup 7  1987  
1582-09-8  Trifluralin  3  53  1991  
16065-83-1  Chromium (III) compounds  3  49  1990  
16071-86-6  CI Direct Brown 95 (see Benzidine, dyes metabolized to)        
1615-80-1  1,2-Diethylhydrazine  2B  4, Sup 7, 71  1999  
1634-04-4  Methyl tert-butyl ether  3  73  1999  
16543-55-8, 64091-91-4  N'-Nitrosonornicotine (NNN) and 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK)  1  Sup 7, 89, 100E  2012  NB Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
16568-02-8  Gyromitrin  3  31, Sup 7  1987  
1675-54-3  Bisphenol A diglycidyl ether (Araldite)  3  47, 71  1999  
1689-82-3  4-Hydroxyazobenzene  3  8, Sup 7  1987  
1694-09-3  Benzyl violet 4B  2B  16, Sup 7  1987  
16984-48-8  Fluorides (inorganic, used in drinking-water)  3  27, Sup 7  1987  
1705-85-7  6-Methylchrysene  3  Sup 7, 92  2010  
1706-01-0  3-Methylfluoranthene  3  Sup 7, 92  2010  
17117-34-9  3-Nitrobenzanthrone  2B  105  2014  NB Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
1746-01-6  2,3,7,8-Tetrachlorodibenzo-para-dioxin  1  Sup 7, 69, 100F  2012  
1836-75-5  Nitrofen (technical-grade)  2B  30, Sup 7  1987  
18540-29-9  Chromium (VI) compounds  1  Sup 7, 49, 100C  2012  
18883-66-4  Streptozotocin  2B  17, Sup 7  1987  
189-55-9  Dibenzo[a,i]pyrene  2B  92  2010  
189-64-0  Dibenzo[a,h]pyrene  2B  Sup 7, 92  2010  
1897-45-6  Chlorothalonil  2B  Sup 7, 73  1999  
191-07-1  Coronene  3  32, Sup 7, 92  1987  
191-24-2  Benzo[ghi]perylene  3  92, Sup 7  2010  
191-26-4  Anthanthrene  3  92, Sup 7  2010  
191-30-0  Dibenzo[a,l]pyrene  2A  Sup 7, 92  2010  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
1912-24-9  Atrazine  3  53, 73  1999  NB Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
1918-02-1  Picloram  3  53  1991  
192-47-2  Dibenzo[h,rst]pentaphene  3  Sup 7, 92  2010  
192-51-8  Dibenzo[e,l]pyrene  3  92  2010  
192-65-4  Dibenzo[a,e]pyrene  3  Sup 7, 92  2010  
192-97-2  Benzo[e]pyrene  3  92, Sup 7  2010  
193-09-9  Naphtho[2,3-e]pyrene  3  92  2010  
193-39-5  Indeno[1,2,3-cd]pyrene  2B  Sup 7, 92  2010  
1936-15-8  CI Orange G  3  8, Sup 7  1987  
1936-15-8  Orange G (see CI Orange G)        
1937-37-7  CI Direct Black 38 (see Benzidine, dyes metabolized to)        
194-59-2  7H-Dibenzo[c,g]carbazole  2B  32, Sup 7, 103  2013  
195-19-7  Benzo[c]phenanthrene  2B  92, Sup 7  2010  NB Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
1954-28-5  Triethylene glycol diglycidyl ether  3  11, Sup 7, 71  1999  
196-78-1  Benzo[g]chrysene  3  92  2010  
198-55-0  Perylene  3  Sup 7, 92  2010  
20073-24-9  3-Carbethoxypsoralen  3  40, Sup 7  1987  
202-33-5  Benz[j]aceanthrylene  2B  92  2010  NB Overall evaluation upgraded to Group 2B with supporting mechanistic and other relevant data
202-94-8  11H-Benz[bc]aceanthrylene  3  92  2010  
202-98-2  4H-Cyclopenta[def]chrysene  3  92  2010  
20268-51-3  7-Nitrobenz[a]anthracene  3  46  1989  
203-12-3  Benzo[ghi]fluoranthene  3  92, Sup 7  2010  
203-20-3  Naphtho[2,1-a]fluoranthene  3  92  2010  
203-33-8  Benzo[a]fluoranthene  3  92, Sup 7  2010  
205-12-9  Benzo[c]fluorene  3  92, Sup 7  2010  
205-82-3  Benzo[j]fluoranthene  2B  92  2010  
205-99-2  Benzo[b]fluoranthene  2B  92  2010  
20589-63-3  3-Nitroperylene  3  46  1989  
206-44-0  Fluoranthene  3  Sup 7, 92  2010  
2068-78-2  Vincristine sulfate  3  26, Sup 7  1987  
207-08-9  Benzo[k]fluoranthene  2B  92  2010  
207-83-0  13H-Dibenzo[a,g]fluorene  3  92  2010  
20830-75-5  Digoxin  2B  108  2016  
20830-81-3  Daunomycin  2B  10, Sup 7  1987  
20941-65-5  Ethyl tellurac  3  12, Sup 7  1987  
211-91-6  Benz[l]aceanthrylene  3  92  2010  
21259-20-1  T2-Trichothecene  3  31, Sup 7  1987  
213-46-7  Picene  3  92  2010  
214-17-5  Benzo[b]chrysene  3  92  2010  
215-58-7  Dibenz[a,c]anthracene  3  Sup 7, 92  2010  
2164-17-2  Fluometuron  3  30, Sup 7  1987  
2168-68-5  Bis(1-aziridinyl)morpholinophosphine sulfide  3  9, Sup 7  1987  
217-59-4  Triphenylene  3  Sup 7, 92  2010  
218-01-9  Chrysene  2B  92  2010  
21884-44-6  Luteoskyrin  3  10, Sup 7  1987  
22248-79-9  Tetrachlorvinphos  2B  30, Sup 7, 112  2017  
22349-59-3  1,4-Dimethylphenanthrene  3  Sup 7, 92  2010  
22398-80-7  Indium phosphide  2A  86  2006  NB Overall evaluation upgraded to Group 2A
224-41-9  Dibenz[a,j]anthracene  3  Sup 7, 92  2010  
224-42-0  Dibenz[a,j]acridine  2A  32, Sup 7, 103  2013  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
224-53-3  Dibenz[c,h]acridine  2B  103  2013  NB Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
2243-62-1  1,5-Naphthalenediamine  3  27, Sup 7  1987  
225-11-6  Benz[a]acridine  3  32, Sup 7, 103  2013  
225-51-4  Benz[c]acridine  3  32, Sup 7, 103  2013  
22506-53-2  3,9-Dinitrofluoranthene  2B  46, 65, 105  2014  
22571-95-5  Symphytine  3  31, Sup 7  1987  
226-36-8  Dibenz[a,h]acridine  2B  32, Sup 7, 103  2013  
22966-79-6  Oestradiol mustard  3  9, Sup 7  1987  
22975-76-4  4,4'-Dimethylangelicin plus ultraviolet A radiation  3  Sup 7  1987  
2303-16-4  Diallate  3  30, Sup 7  1987  
2318-18-5  Senkirkine  3  31, Sup 7  1987  
23214-92-8  Adriamycin  2A  10, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
23246-96-0  Riddelliine  2B  10, Sup 7, 82  2002  
23255-93-8  Hycanthone mesylate  3  13, Sup 7  1987  
2353-45-9  Fast Green FCF  3  16, Sup 7  1987  
23537-16-8  Rugulosin  3  40, Sup 7  1987  
23746-34-1  Potassium bis(2-hydroxyethyl)dithiocarbamate  3  12, Sup 7  1987  
238-84-6  Benzo[a]fluorene  3  92, Sup 7  2010  
2385-85-5  Mirex  2B  20, Sup 7  1987  
2386-90-5  Bis(2,3-epoxycyclopentyl)ether  3  47, 71  1999  
239-35-0  Benzo[b]naphtho[2,1-d]thiophene  3  103  2013  
2425-06-1  Captafol  2A  53  1991  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
2425-85-6  CI Pigment Red 3  3  57  1993  
2426-08-6  1-Butyl glycidyl ether  2B  125  2020 online  
2429-74-5  CI Direct Blue 15  2B  57  1993  
243-17-4  Benzo[b]fluorene  3  92, Sup 7  2010  
2432-99-7  11-Aminoundecanoic acid  3  39, Sup 7  1987  
24560-98-3  cis-9,10-Epoxystearic acid  3  11, Sup 7, 71  1999  
2475-45-8  Disperse Blue 1  2B  48  1990  
24938-64-5  para-Aramid fibrils  3  68  1997  
25013-15-4  Vinyl toluene  3  60  1994  
25013-16-5  Butylated hydroxyanisole (BHA)  2B  40, Sup 7  1987  
25038-54-4  Nylon 6  3  19, Sup 7  1987  
25732-74-5  Acepyrene (3,4-dihydrocyclopenta[cd]pyrene)  3  92  2010  
25812-30-0  Gemfibrozil  3  66  1996  
25962-77-0  trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)-vinyl]-1,3,4-oxadiazole  2B  7, Sup 7  1987  
2602-46-2  CI Direct Blue 6 (see Benzidine, dyes metabolized to)        
26148-68-5  A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole)  2B  40, Sup 7  1987  
262-12-4  Dibenzo-para-dioxin  3  69  1997  
26308-28-1  Ripazepam  3  66  1996  
2646-17-5  Oil Orange SS  2B  8, Sup 7  1987  
26471-62-5  Toluene diisocyanates  2B  39, Sup 7, 71  1999  
26782-43-4  Hydroxysenkirkine  3  10, Sup 7  1987  
271-89-6  Benzofuran  2B  63  1995  
27208-37-3  Cyclopenta[cd]pyrene  2A  Sup 7, 92  2010  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
2757-90-6  Agaritine  3  31, Sup 7  1987  
2783-94-0  Sunset Yellow FCF  3  8, Sup 7  1987  
2784-94-3  HC Blue No. 1  2B  57  1993  
2832-40-8  Disperse Yellow 3  3  48  1990  
2835-39-4  Allyl isovalerate  3  36, Sup 7, 71  1999  
28407-37-8  CI Direct Blue 218  2B  129  In prep.  
28434-86-8  3,3'-Dichloro-4,4'-diaminodiphenyl ether  2B  16, Sup 7  1987  
2871-01-4  HC Red No. 3  3  57  1993  
29069-24-7  Prednimustine  3  50  1990  
29291-35-8  N-Nitrosofolic acid  3  17, Sup 7  1987  
2955-38-6  Prazepam  3  66  1996  
2973-10-6  Diisopropyl sulfate  2B  54, 71  1999  
29767-20-2  Teniposide  2A  76  2000  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
298-00-0  Methyl parathion  3  30, Sup 7  1987  
298-81-7  Methoxsalen (8-methoxypsoralen) plus ultraviolet A radiation  1  24, Sup 7, 100A  2012  
299-75-2  Treosulfan  1  26, Sup 7, 100A  2012  
29975-16-4  Estazolam  3  66  1996  
3018-12-0  Dichloroacetonitrile  3  52, 71  1999  
302-01-2  Hydrazine  2A  4, Sup 7, 71, 115  2018  
302-17-0  Chloral hydrate  2A  63, 84, 106  2014  
303-34-4  Lasiocarpine  2B  10, Sup 7  1987  
303-47-9  Ochratoxin A  2B  Sup 7, 56  1993  
30310-80-6  N-Nitrosohydroxyproline  3  17, Sup 7  1987  
305-03-3  Chlorambucil  1  26, Sup 7, 100A  2012  
30516-87-1  Zidovudine (AZT)  2B  76  2000  
3068-88-0  beta-Butyrolactone  2B  11, Sup 7, 71  1999  
308068-56-6  Carbon nanotubes, multiwalled MWCNT-7  2B  111  2017  
308068-56-6  Carbon nanotubes, multiwalled, other than MWCNT-7  3  111  2017  
308068-56-6  Carbon nanotubes, single-walled  3  111  2017  
308068-56-6  Multiwalled carbon nanotubes MWCNT-7 (see Carbon nanotubes, multiwalled MWCNT-7)        
308068-56-6  Multiwalled carbon nanotubes other than MWCNT-7 (see Carbon nanotubes, multiwalled, other than MWCNT-7)        
308068-56-6  Single-walled carbon nanotubes (see Carbon nanotubes, single-walled)        
308076-74-6  Silicon carbide, fibrous  2B  111  2017  
309-00-2  Aldrin (see Dieldrin, and aldrin metabolized to dieldrin)        
3118-97-6  Sudan II  3  8, Sup 7  1987  
313-67-7  Aristolochic acid  1  82, 100A  2012  NB Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
313-67-7  Aristolochic acid, plants containing  1  82, 100A  2012  
314-13-6  Evans blue  3  8, Sup 7  1987  
315-18-4  Zectran  3  12, Sup 7  1987  
315-22-0  Monocrotaline  2B  10, Sup 7  1987  
3173-72-6  1,5-Naphthalene diisocyanate  3  19, Sup 7, 71  1999  
320-67-2  Azacitidine  2A  50  1990  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
3252-43-5  Dibromoacetonitrile  2B  52, 71, 101  2013  
3296-90-0  2,2-Bis(bromomethyl)propane-1,3-diol  2B  77  2000  
331-39-5  Caffeic acid  2B  56  1993  
33229-34-4  HC Blue No. 2  3  57  1993  
333-41-5  Diazinon  2A  112  2017  NB Overall evaluation upgraded to Group 2A based on mechanistic evidence
334-88-3  Diazomethane  3  7, Sup 7  1987  
33419-42-0  Etoposide  1  76, 100A  2012  NB Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
33419-42-0, 15663-27-1, 11056-06-7  Etoposide in combination with cisplatin and bleomycin  1  76, 100A  2012  
335-67-1  Perfluorooctanoic acid (PFOA)  2B  110  2017  
3351-28-8  1-Methylchrysene  3  Sup 7, 92  2010  
3351-30-2  4-Methylchrysene  3  Sup 7, 92  2010  
3351-31-3  3-Methylchrysene  3  Sup 7, 92  2010  
3351-32-4  2-Methylchrysene  3  Sup 7, 92  2010  
33543-31-6  2-Methylfluoranthene  3  Sup 7, 92  2010  
3564-09-8  Ponceau 3R  2B  8, Sup 7  1987  
3567-69-9  Carmoisine  3  8, Sup 7  1987  
3570-75-0  2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole  2B  7, Sup 7  1987  
366-70-1  Procarbazine hydrochloride  2A  26, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
3688-53-7  AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide]  2B  31, Sup 7  1987  
3697-24-3  5-Methylchrysene  2B  Sup 7, 92  2010  
37319-17-8  Pentosan polysulfate sodium  2B  108  2016  
3761-53-3  Ponceau MX  2B  8, Sup 7  1987  
37620-20-5  N'-Nitrosoanabasine (NAB)  3  37, Sup 7, 89  2007  
3771-19-5  Nafenopin  2B  24, Sup 7  1987  
3778-73-2  Isophosphamide  3  26, Sup 7  1987  
3795-88-8  5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)?amino]-2-oxazolidinone  2B  7, Sup 7  1987  
3844-45-9  Brilliant Blue FCF, disodium salt  3  16, Sup 7  1987  
38571-73-2  1,2,3-Tris(chloromethoxy)propane  3  15, Sup 7, 71  1999  
3902-71-4  4,5',8-Trimethylpsoralen  3  40, Sup 7  1987  
396-01-0  Triamterene  2B  108  2016  
4063-41-6  4,5'-Dimethylangelicin plus ultraviolet A radiation  3  Sup 7  1987  
40762-15-0  Doxefazepam  3  66  1996  
409-21-2  Silicon carbide whiskers  2A  111  2017  
4170-30-3  Crotonaldehyde  2B  63 (corr. 65), 128  In prep.  
420-12-2  Ethylene sulfide  3  11, Sup 7  1987  
42397-64-8  1,6-Dinitropyrene  2B  46, 105  2014  
42397-65-9  1,8-Dinitropyrene  2B  Sup 7, 46, 105  2014  
4342-03-4  Dacarbazine  2B  26, Sup 7  1987  
439-14-5  Diazepam  3  Sup 7, 66  1996  
443-48-1  Metronidazole  2B  13, Sup 7  1987  
446-86-6  Azathioprine  1  26, Sup 7, 100A  2012  
4548-53-2  Ponceau SX  3  8, Sup 7  1987  
4549-40-0  N-Nitrosomethylvinylamine  2B  17, Sup 7  1987  
4657-93-6  5-Aminoacenaphthene  3  16, Sup 7  1987  
4680-78-8  Guinea Green B  3  16, Sup 7  1987  
480-54-6  Retrorsine  3  10, Sup 7  1987  
480-81-9  Seneciphylline  3  10, Sup 7  1987  
484-20-8  5-Methoxypsoralen  2A  40, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
492-17-1  2,4'-Diphenyldiamine  3  16, Sup 7  1987  
492-80-8  Auramine  2B  1, Sup 7, 99, 100F  2012  
493-52-7  Methyl red  3  8, Sup 7  1987  
494-03-1  N,N-Bis(2-chloroethyl)-2-naphthylamine (see Chlornaphazine)        
494-03-1  Chlornaphazine  1  4, Sup 7, 100A  2012  
494-38-2  Acridine orange  3  16, Sup 7  1987  
50-00-0  Formaldehyde  1  Sup 7, 62, 88, 100F  2012  
50-06-6  Phenobarbital  2B  Sup 7, 79  2001  
50-07-7  Mitomycin C  2B  10, Sup 7  1987  
50-18-0, 6055-19-2  Cyclophosphamide  1  26, Sup 7, 100A  2012  
50-29-3  DDT (4,4'-dichlorodiphenyltrichloroethane)  2A  Sup 7, 53, 113  2018  
50-32-8  Benzo[a]pyrene  1  Sup 7, 92, 100F  2012  NB Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
50-33-9  Phenylbutazone  3  13, Sup 7  1987  
50-41-9  Clomiphene citrate  3  21, Sup 7  1987  
50-44-2  6-Mercaptopurine  3  26, Sup 7  1987  
50-55-5  Reserpine  3  24, Sup 7  1987  
50-76-0  Actinomycin D  3  10, Sup 7  1987  
501-30-4  Kojic acid  3  79  2001  
505-60-2  Mustard gas (see Sulfur mustard)        
505-60-2  Sulfur mustard  1  9, Sup 7, 100F  2012  
509-14-8  Tetranitromethane  2B  65  1996  
50926-11-9  Indium tin oxide  2B  118  2018 online  
51-02-5  Pronetalol hydrochloride  3  13, Sup 7  1987  
51-03-6  Piperonyl butoxide  3  30, Sup 7  1987  
51-18-3  2,4,6-Tris(1-aziridinyl)-s-triazine  3  9, Sup 7  1987  
51-21-8  5-Fluorouracil  3  26, Sup 7  1987  
51-52-5  Propylthiouracil  2B  Sup 7, 79  2001  
51-75-2  Nitrogen mustard  2A  9, Sup 7  1987  
51-79-6  Ethyl carbamate (Urethane)  2A  7, Sup 7, 96  2010  
510-15-6  Chlorobenzilate  3  30, Sup 7  1987  
51264-14-3  Amsacrine  2B  76  2000  
513-37-1  1-Chloro-2-methylpropene  2B  63  1995  
5131-60-2  4-Chloro-meta-phenylenediamine  3  27, Sup 7  1987  
5141-20-8  Light Green SF  3  16, Sup 7  1987  
51481-61-9  Cimetidine  3  50  1990  
5160-02-1  D & C Red No. 9  3  Sup 7, 57  1993  
51630-58-1  Fenvalerate  3  53  1991  
518-75-2  Citrinin  3  40, Sup 7  1987  
52-01-7  Spironolactone  3  Sup 7, 79  2001  
52-24-4  Thiotepa  1  Sup 7, 50, 100A  2012  
52-46-0  Apholate  3  9, Sup 7  1987  
52-68-6  Trichlorfon  3  30, Sup 7  1987  
520-18-3  Kaempferol  3  31, Sup 7  1987  
523-44-4  CI Acid Orange 20  3  8, Sup 7  1987  
523-44-4  Orange I (see CI Acid Orange 20)        
523-50-2  Angelicin plus ultraviolet A radiation  3  40, Sup 7  1987  
52645-53-1  Permethrin  3  53  1991  
52918-63-5  Deltamethrin  3  53  1991  
53-03-2  Prednisone  3  26, Sup 7  1987  
53-70-3  Dibenz[a,h]anthracene  2A  Sup 7, 92  2010  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
5307-14-2  1,4-Diamino-2-nitrobenzene  3  Sup 7, 57  1993  
531-76-0  Merphalan  2B  9, Sup 7  1987  
531-82-8  N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide  2B  7, Sup 7  1987  
532-82-1  Chrysoidine  3  8, Sup 7  1987  
536-33-4  Ethionamide  3  13, Sup 7  1987  
5385-75-1  Dibenzo[a,e]fluoranthene  3  Sup 7, 92  2010  
53973-98-1  Carrageenan, degraded (Poligeenan)  2B  31, Sup 7  1987  
53973-98-1  Poligeenan (see Carrageenan, degraded)        
54-05-7  Chloroquine  3  13, Sup 7  1987  
54-31-9  Furosemide (Frusemide)  3  50  1990  
54-85-3  Isonicotinic acid hydrazide (Isoniazid)  3  4, Sup 7  1987  
540-73-8  1,2-Dimethylhydrazine  2A  4, Sup 7, 71  1999  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
541-73-1  meta-Dichlorobenzene  3  73  1999  
542-56-3  Isobutyl nitrite  2B  122  2019  
542-75-6  1,3-Dichloropropene (technical-grade)  2B  41, Sup 7, 71  1999  
542-78-9  Malonaldehyde  3  36, Sup 7, 71  1999  
542-88-1, 107-30-2  Bis(chloromethyl)ether; chloromethyl methyl ether (technical-grade)  1  4, Sup 7, 100F  2012  
5431-33-4  Glycidyl oleate  3  11, Sup 7  1987  
545-06-2  Trichloroacetonitrile  3  52, 71  1999  
545-55-1  Tris(1-aziridinyl)phosphine oxide  3  9, Sup 7  1987  
5456-28-0  Ethyl selenac  3  12, Sup 7  1987  
54749-90-5  Chlorozotocin  2A  50  1990  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
548-62-9  Gentian violet (see also Leucogentian violet)  2B  129  In prep.  
55-18-5  N-Nitrosodiethylamine  2A  17, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
55-98-1  1,4-Butanediol dimethanesulfonate (see Busulfan)        
55-98-1  Busulfan  1  4, Sup 7, 100A  2012  
55-98-1  Myleran (see Busulfan)        
551-74-6  Mannomustine dihydrochloride  3  9, Sup 7  1987  
5522-43-0  1-Nitropyrene  2A  Sup 7, 46, 105  2014  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
555-84-0  1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone  2B  7, Sup 7  1987  
55557-01-2  N-Nitrosoguvacine  3  Sup 7, 85  2004  
55557-02-3  N-Nitrosoguvacoline  3  Sup 7, 85  2004  
556-52-5  Glycidol  2A  77  2000  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
5589-96-8  Bromochloroacetic acid  2B  101  2013  
56-04-2  Methylthiouracil  2B  Sup 7, 79  2001  
56-23-5  Carbon tetrachloride  2B  20, Sup 7, 71  1999  
56-25-7  Cantharidin  3  10, Sup 7  1987  
56-38-2  Parathion  2B  30, Sup 7, 112  2017  
56-53-1  Diethylstilbestrol  1  21, Sup 7, 100A  2012  
56-55-3  Benz[a]anthracene  2B  92, Sup 7  2010  
56-75-7  Chloramphenicol  2A  Sup 7, 50  1990  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
562-10-7  Doxylamine succinate  3  79  2001  
563-41-7  Semicarbazide hydrochloride  3  12, Sup 7  1987  
563-47-3  3-Chloro-2-methylpropene, technical grade  2B  63, 115  2018  
56894-91-8  1,4-Bis(chloromethoxymethyl)benzene  3  15, Sup 7, 71  1999  
569-61-9  CI Basic Red 9  2B  57, 99  2010  
569-64-2, 14426-28-9, 2437-29-8  Malachite green (see also Leucomalachite green)  3  129  In prep.  
57-06-7  Allyl isothiocyanate  3  73, Sup 7  1999  
57-14-7  1,1-Dimethylhydrazine  2B  4, Sup 7, 71  1999  
57-39-6  Tris(2-methyl-1-aziridinyl)phosphine oxide  3  9, Sup 7  1987  
57-41-0  Phenytoin  2B  Sup 7, 66  1996  
57-57-8  beta-Propiolactone  2B  4, Sup 7, 71  1999  
57-68-1  Sulfamethazine  3  79  2001  NB Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
57-74-9  Chlordane  2B  Sup 7, 53, 79  2001  
57-88-5  Cholesterol  3  31, Sup 7  1987  
57018-52-7  1-tert-Butoxypropan-2-ol  2B  88, 119  2019  
57117-31-4  2,3,4,7,8-Pentachlorodibenzofuran  1  100F  2012  NB Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
57465-28-8  3,4,5,3’,4’-Pentachlorobiphenyl (PCB-126)  1  100F  2012  See Polychlorinated biphenyls, dioxin-like, with a TEF according to WHO
57835-92-4  4-Nitropyrene  2B  46, 105  2014  
58-08-2  Caffeine  3  51  1991  
58-14-0  Pyrimethamine  3  13, Sup 7  1987  
58-55-9  Theophylline  3  51  1991  
58-89-9  Lindane (see also Hexachlorocyclohexanes)  1  113  2018  
58-93-5  Hydrochlorothiazide  2B  50, 108  2016  
581-89-5  2-Nitronaphthalene  3  46  1989  
59-05-2  Methotrexate  3  26, Sup 7  1987  
59-87-0  Nitrofural (Nitrofurazone)  3  50  1990  
59-89-2  N-Nitrosomorpholine  2B  17, Sup 7  1987  
592-62-1  Methylazoxymethanol acetate  2B  10, Sup 7  1987  
59277-89-3  Aciclovir  3  76  2000  
593-60-2  Vinyl bromide  2A  39, Sup 7, 71, 97  2008  NB (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl bromide should be considered to act similarly to the human carcinogen vinyl chloride
593-70-4  Chlorofluoromethane  3  41, Sup 7, 71  1999  
59536-65-1  Polybrominated biphenyls  2A  41, Sup 7, 107  2016  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data, namely mechanistic similarity with polychlorinated biphenyls classified in Group 1
598-55-0  Methyl carbamate  3  12, Sup 7  1987  
59820-43-8  HC Yellow No. 4  3  57  1993  
59865-13-3, 79217-60-0  Ciclosporin (see Cyclosporine)        
59865-13-3, 79217-60-0  Cyclosporine  1  50, 100A  2012  
5989-27-5  d-Limonene  3  56, 73  1999  NB Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
599-79-1  Sulfasalazine  2B  108  2016  
60-09-3  para-Aminoazobenzene  2B  8, Sup 7  1987  
60-11-7  para-Dimethylaminoazobenzene  2B  8, Sup 7  1987  
60-35-5  Acetamide  2B  7, Sup 7, 71  1999  
60-56-0  Methimazole  3  79  2001  
60-57-1  Dieldrin (see Dieldrin, and aldrin metabolized to dieldrin)        
60-57-1, 309-00-2  Dieldrin, and aldrin metabolized to dieldrin  2A  5, Sup 7, 117  2019  
60102-37-6  Petasitenine  3  31, Sup 7  1987  
60153-49-3  3-(N-Nitrosomethylamino)propionitrile  2B  Sup 7, 85  2004  
602-60-8  9-Nitroanthracene  3  33, Sup 7  1987  
602-87-9  5-Nitroacenaphthene  2B  16, Sup 7  1987  
603-48-5  Leucogentian violet (see also Gentian violet)  3  129  In prep.  
604-75-1  Oxazepam  2B  Sup 7, 66  1996  
606-20-2  2,6-Dinitrotoluene  2B  65  1996  
607-57-8  2-Nitrofluorene  2B  46, 105  2014  
609-20-1  2,6-Dichloro-para-phenylenediamine  3  39, Sup 7  1987  
61-57-4  Niridazole  2B  13, Sup 7  1987  
61-82-5  Amitrole  3  79, Sup 7  2001  NB Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
611-06-3  2,4-Dichloro-1-nitrobenzene  2B  123  2020 online  
613-35-4  N,N'-Diacetylbenzidine  2B  16, Sup 7  1987  
615-05-4  2,4-Diaminoanisole  2B  Sup 7, 79  2001  
615-28-1  ortho-Phenylenediamine dihydrochloride  2B  123  2020 online  
615-53-2  N-Methyl-N-nitrosourethane  2B  4, Sup 7  1987  
6164-98-3  Chlordimeform  3  30, Sup 7  1987  
618-85-9  3,5-Dinitrotoluene  3  65  1996  
62-44-2  Phenacetin  1  24, Sup 7, 100A  2012  NB Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data
62-50-0  Ethyl methanesulfonate  2B  7, Sup 7  1987  
62-53-3  Aniline (see also Aniline hydrochloride)  2A  27, Sup 7, 127  In prep.  
62-55-5  Thioacetamide  2B  7, Sup 7  1987  
62-56-6  Thiourea  3  Sup 7, 79  2001  
62-73-7  Dichlorvos  2B  Sup 7, 53  1991  
62-75-9  N-Nitrosodimethylamine  2A  17, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
621-64-7  N-Nitrosodi-n-propylamine  2B  17, Sup 7  1987  
62450-06-0  Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole)  2B  31, Sup 7  1987  
62450-07-1  Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole)  2B  31, Sup 7  1987  
627-12-3  n-Propyl carbamate  3  12, Sup 7  1987  
63-25-2  Carbaryl  3  12, Sup 7  1987  
63-92-3  Phenoxybenzamine hydrochloride  2B  24, Sup 7  1987  
630-20-6  1,1,1,2-Tetrachloroethane  2B  41, Sup 7, 71, 106  2014  
63041-90-7  6-Nitrobenzo[a]pyrene  3  Sup 7, 46  1989  
631-64-1  Dibromoacetic acid  2B  101  2013  
632-99-5  Magenta  2B  Sup 7, 57, 99, 100F  2012  
6358-53-8  Citrus Red No. 2  2B  8, Sup 7  1987  
6368-72-5  Sudan Red 7B  3  8, Sup 7  1987  
637-07-0  Clofibrate  3  Sup 7, 66  1996  
6373-74-6  CI Acid Orange 3  3  57  1993  
64-17-5  Ethanol in alcoholic beverages  1  96, 100E  2012  
64-67-5  Diethyl sulfate  2A  54, 71  1999  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
641-48-5  Dihydroaceanthrylene  3  92  2010  
6416-57-5  Sudan Brown RR  3  8, Sup 7  1987  
64436-13-1  Arsenobetaine and other organic arsenic compounds that are not metabolized in humans  3  100C  2012  
6459-94-5  CI Acid Red 114  2B  57  1993  
64742-93-4  Bitumens, occupational exposure to oxidized bitumens and their emissions during roofing  2A  103  2013  
65271-80-9  Mitoxantrone  2B  76  2000  
65996-93-2  Coal-tar pitch  1  35, Sup 7, 100F  2012  
66-27-3  Methyl methanesulfonate  2A  7, Sup 7, 71  1999  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
66-75-1  Uracil mustard  2B  9, Sup 7  1987  
66733-21-9  Erionite  1  42, Sup 7, 100C  2012  
67-20-9  Nitrofurantoin  3  50  1990  
67-45-8  Furazolidone  3  31, Sup 7  1987  
67-63-0  Isopropyl alcohol  3  15, Sup 7, 71  1999  
67-66-3  Chloroform  2B  Sup 7, 73  1999  
67-72-1  Hexachloroethane  2B  73  1999  
67730-10-3  Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole)  2B  40, Sup 7  1987  
67730-11-4  Glu-P-1 (2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole)  2B  40, Sup 7  1987  
6795-23-9  Aflatoxin M1  2B  56  1993  
68-12-2  N,N-Dimethylformamide  2A  47, 71, 115  2018  
68-76-8  Tris(aziridinyl)-para-benzoquinone (Triaziquone)  3  9, Sup 7  1987  
680-31-9  Hexamethylphosphoramide  2B  15, Sup 7, 71  1999  
68006-83-7  MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole)  2B  40, Sup 7  1987  
68308-34-9  Shale oils  1  35, Sup 7, 100F  2012  
684-93-5  N-Methyl-N-nitrosourea  2A  17, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
68603-42-9  Coconut oil diethanolamine condensate  2B  101  2013  
6870-67-3  Jacobine  3  10, Sup 7  1987  
69-53-4  Ampicillin  3  50  1990  
693-98-1  2-Methylimidazole  2B  101  2013  
69655-05-6  Didanosine  3  76  2000  
70-25-7  N-Methyl-N?-nitro-N-nitrosoguanidine (MNNG)  2A  4, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
70-30-4  Hexachlorophene  3  20, Sup 7  1987  
7099-43-6  5,6-Cyclopenteno-1,2-benzanthracene  3  92  2010  
71-43-2  Benzene  1  29, Sup 7. 100F, 120  2018  
71-55-6  1,1,1-Trichloroethane  3  20, Sup 7, 71  1999  
71-58-9  Medroxyprogesterone acetate  2B  21, Sup 7  1987  
712-68-5  2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole  2B  7, Sup 7  1987  
71267-22-6  N'-Nitrosoanatabine (NAT)  3  37, Sup 7, 89  2007  
72-20-8  Endrin  3  5, Sup 7  1987  
72-43-5  Methoxychlor  3  20, Sup 7  1987  
72-57-1  Trypan blue  2B  8, Sup 7  1987  
7220-79-3  Methylene blue  3  108  2016  
723-46-6  Sulfamethoxazole  3  Sup 7, 79  2001  
73459-03-7  5-Methylangelicin plus ultraviolet A radiation  3  Sup 7  1987  
74-83-9  Methyl bromide  3  41, Sup 7, 71  1999  
74-85-1  Ethylene  3  Sup 7, 60  1994  
74-87-3  Methyl chloride  3  41, Sup 7, 71  1999  
74-88-4  Methyl iodide  3  41, Sup 7, 71  1999  
74-96-4  Bromoethane  3  52, 71  1999  
7439-92-1  Lead  2B  23, Sup 7  1987  
7439-97-6  Mercury and inorganic mercury compounds  3  58  1993  
7440-02-0  Nickel, metallic  2B  Sup 7, 49  1990  
7440-07-5  Plutonium  1  78, 100D  2012  
7440-29-1  Thorium-232 and its decay products  1  78, 100D  2012  
7440-38-2  Arsenic and inorganic arsenic compounds  1  23, Sup 7, 100C  2012  
7440-41-7  Beryllium and beryllium compounds  1  Sup 7, 58, 100C  2012  
7440-43-9  Cadmium and cadmium compounds  1  58, 100C  2012  
7440-47-3  Chromium, metallic  3  Sup 7, 49  1990  
7440-48-4  Cobalt and cobalt compounds  2B  52  1991  NB Evaluated as a group
7440-48-4  Cobalt metal without tungsten carbide  2B  86  2006  
7440-48-4, 12070-12-1  Cobalt metal with tungsten carbide  2A  86  2006  
7446-09-5  Sulfur dioxide  3  54  1992  
7460-84-6  Glycidyl stearate  3  11, Sup 7  1987  
7481-89-2  Zalcitabine  2B  76  2000  
7496-02-8  6-Nitrochrysene  2A  Sup 7, 46, 105  2014  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
75-00-3  Chloroethane  3  52, 71  1999  
75-01-4  Vinyl chloride  1  Sup 7, 97, 100F  2012  
75-02-5  Vinyl fluoride  2A  Sup 7, 63, 97  2008  NB (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride
75-07-0  Acetaldehyde  2B  36, Sup 7, 71  1999  
75-07-0  Acetaldehyde associated with consumption of alcoholic beverages  1  100E  2012  
75-09-2  Dichloromethane (Methylene chloride)  2A  Sup 7, 71, 110  2017  
75-21-8  Ethylene oxide  1  Sup 7, 60, 97, 100F  2012  NB Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
75-25-2  Bromoform  3  52, 71  1999  
75-27-4  Bromodichloromethane  2B  52, 71  1999  
75-35-4  Vinylidene chloride  2B  39, Sup 7, 71, 119  2019  
75-38-7  Vinylidene fluoride  3  39, Sup 7, 71  1999  
75-45-6  Chlorodifluoromethane  3  41, Sup 7, 71  1999  
75-52-5  Nitromethane  2B  77  2000  
75-55-8  2-Methylaziridine (Propyleneimine)  2B  9, Sup 7, 71  1999  
75-56-9  Propylene oxide  2B  Sup 7, 60  1994  
75-60-5  Dimethylarsinic acid  2B  100C  2012  
75-87-6  Chloral  2A  63, 84, 106  2014  
75-88-7  2-Chloro-1,1,1-trifluoroethane  3  41, Sup 7, 71  1999  
7519-36-0  N-Nitrosoproline  3  17, Sup 7  1987  
75321-20-9  1,3-Dinitropyrene  2B  46, 105  2014  
7572-29-4  Dichloroacetylene  3  39, Sup 7, 71  1999  
759-73-9  N-Ethyl-N-nitrosourea  2A  17, Sup 7  1987  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
76-01-7  Pentachloroethane  3  41, Sup 7, 71  1999  
76-03-9  Trichloroacetic acid  2B  63, 84, 106  2014  
76-44-8  Heptachlor  2B  Sup 7, 53, 79  2001  
76180-96-6  IQ (2-Amino-3-methylimidazo[4,5-f]quinoline)  2A  Sup 7, 56  1993  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
7631-86-9  Silica, amorphous  3  Sup 7, 68  1997  
7647-01-0  Hydrochloric acid  3  54  1992  
765-34-4  Glycidaldehyde  2B  11, Sup 7, 71  1999  
7664-93-9  Strong-inorganic-acid mists containing sulfuric acid (see Acid mists)        
77-09-8  Phenolphthalein  2B  76  2000  
77-78-1  Dimethyl sulfate  2A  4, Sup 7, 71  1999  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
77094-11-2  MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline)  2B  Sup 7, 56  1993  
7722-84-1  Hydrogen peroxide  3  36, Sup 7, 71  1999  
77439-76-0  3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone  2B  84  2004  
77500-04-0  MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline)  2B  Sup 7, 56  1993  
7758-01-2  Potassium bromate  2B  Sup 7, 73  1999  
7758-19-2  Sodium chlorite  3  52  1991  
7782-49-2  Selenium and selenium compounds  3  9, Sup 7  1987  
78-79-5  Isoprene  2B  60, 71  1999  
78-87-5  1,2-Dichloropropane  1  41, Sup 7, 71, 110  2017  
78-98-8  Methylglyoxal  3  51  1991  
789-07-1  2-Nitropyrene  3  46  1989  
79-00-5  1,1,2-Trichloroethane  3  52, 71  1999  
79-01-6  Trichloroethylene  1  Sup 7, 63, 106  2014  
79-06-1  Acrylamide  2A  60, Sup 7  1994  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
79-10-7  Acrylic acid  3  19, Sup 7, 71  1999  
79-34-5  1,1,2,2-Tetrachloroethane  2B  20, Sup 7, 71, 106  2014  
79-43-6  Dichloroacetic acid  2B  63, 84, 106  2014  
79-44-7  Dimethylcarbamoyl chloride  2A  12, Sup 7, 71  1999  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
79-46-9  2-Nitropropane  2B  29, Sup 7, 71  1999  
79-94-7  Tetrabromobisphenol A  2A  115  2018  NB Overall evaluation upgraded to Group 2A with supporting evidence from mechanistic data
794-93-4  Dihydroxymethylfuratrizine (see also Panfuran S)  3  24, Sup 7  1987  
794-93-4  Panfuran S (containing dihydroxymethylfuratrizine)  2B  24, Sup 7  1987  
80-08-0  Dapsone  3  24, Sup 7  1987  
80-62-6  Methyl methacrylate  3  Sup 7, 60  1994  
800-24-8  Aziridyl benzoquinone  3  9, Sup 7  1987  
8001-35-2  Toxaphene (Polychlorinated camphenes)  2B  Sup 7, 79  2001  
8001-50-1  Terpene polychlorinates (Strobane?)  3  5, Sup 7  1987  
8001-58-9  Creosotes  2A  Sup 7, 92  2010  
8002-05-9  Crude oil  3  45  1989  
8007-45-2  Coal tars (see Coal-tar distillation)    35, Sup 7  1987  
8007-45-2  Coal-tar distillation  1  92, 100F  2012  
8018-07-3  Acriflavinium chloride  3  13, Sup 7  1987  
804-36-4  Nitrovin  3  31, Sup 7  1987  
8047-67-4  Saccharated iron oxide  3  2, Sup 7  1987  
8052-42-4  Bitumens, extracts of steam-refined and air-refined; steam-refined, cracking-residue and air-refined bitumens (see Bitumens, occupational exposures)    35, Sup 7  1987  
8052-42-4, 64741-56-6  Bitumens, occupational exposure to straight-run bitumens and their emissions during road paving  2B  103  2013  
81-07-2  Saccharin and its salts  3  Sup 7, 73  1999  NB Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
81-15-2  Musk xylene  3  65  1996  
81-49-2  1-Amino-2,4-dibromoanthraquinone  2B  101  2013  
81-88-9  Rhodamine B  3  16, Sup 7  1987  
817-09-4  Trichlormethine (Trimustine hydrochloride)  2B  Sup 7, 50  1990  
82-28-0  1-Amino-2-methylanthraquinone  3  27, Sup 7  1987  
82-68-8  Quintozene (Pentachloronitrobenzene)  3  5, Sup 7  1987  
822-36-6  4-Methylimidazole  2B  101  2013  
82413-20-5  Droloxifene  3  66  1996  
828-00-2  Dimethoxane  3  15, Sup 7  1987  
83-32-9  Acenaphthene  3  92  2010  
83-63-6  Diacetylaminoazotoluene  3  8, Sup 7  1987  
83-66-9  Musk ambrette  3  65  1996  
83-67-0  Theobromine  3  51  1991  
832-69-9  1-Methylphenanthrene  3  Sup 7, 92  2010  
83463-62-1  Bromochloroacetonitrile  3  52, 71  1999  
838-88-0  4,4'-Methylene bis(2-methylaniline)  2B  4, Sup 7  1987  
84-65-1  Anthraquinone  2B  101  2013  
842-07-9  Sudan I  3  8, Sup 7  1987  
846-50-4  Temazepam  3  66  1996  
85-01-8  Phenanthrene  3  Sup 7, 92  2010  
85-68-7  Butyl benzyl phthalate  3  Sup 7, 73  1999  
85-83-6  Scarlet Red  3  8, Sup 7  1987  
85-84-7  Yellow AB  3  8, Sup 7  1987  
85-86-9  Sudan III  3  8, Sup 7  1987  
85502-23-4  3-(N-Nitrosomethylamino)propionaldehyde  3  Sup 7, 85  2004  
85878-62-2  Pyrido[3,4-c]psoralen  3  40, Sup 7  1987  
85878-63-3  7-Methylpyrido[3,4-c]psoralen  3  40, Sup 7  1987  
86-30-6  N-Nitrosodiphenylamine  3  27, Sup 7  1987  
86-54-4  Hydralazine  3  24, Sup 7  1987  
86-57-7  1-Nitronaphthalene  3  46  1989  
86-73-7  Fluorene  3  Sup 7, 92  2010  
86-74-8  Carbazole  2B  32, Sup 7, 71, 103  2013  
86-88-4  1-Naphthylthiourea (ANTU)  3  30, Sup 7  1987  
868-85-9  Dimethyl hydrogen phosphite  3  48, 71  1999  
87-29-6  Cinnamyl anthranilate  3  Sup 7, 77  2000  
87-62-7  2,6-Dimethylaniline (2,6-Xylidine)  2B  57  1993  
87-68-3  Hexachlorobutadiene  3  73  1999  
87-86-5  Pentachlorophenol (see also Polychlorophenols)  1  53, 71, 117  2019  
87625-62-5  Ptaquiloside  3  40, Sup 7  1987  
88-05-1  2,4,6-Trimethylaniline  3  27, Sup 7  1987  
88-06-2  2,4,6-Trichlorophenol (see also Polychlorophenols)  2B  117  2019  
88-12-0  N-Vinyl-2-pyrrolidone  3  19, Sup 7, 71  1999  
88-72-2  2-Nitrotoluene  2A  101  2013  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
88-73-3  2-Chloronitrobenzene  2B  65, 123  2020 online  
88-73-3, 121-73-3, 100-00-5  Chloronitrobenzenes (see 2-Chloronitrobenzene, 3-Chloronitrobenzene, 4-Chloronitrobenzene)        
89-61-2  1,4-Dichloro-2-nitrobenzene  2B  65, 123  2020 online  
89-82-7  Pulegone  2B  108  2016  
892-21-7  3-Nitrofluoranthene  3  33, Sup 7  1987  
89778-26-7  Toremifene  3  66  1996  
90-04-0  ortho-Anisidine (see also ortho-Anisidine hydrochloride)  2A  Sup 7, 73, 127  In prep.  
90-43-7  ortho-Phenylphenol  3  73  1999  
90-65-3  Penicillic acid  3  10, Sup 7  1987  
90-94-8  Michler’s ketone [4,4?-Bis(dimethylamino)?benzophenone]  2B  99  2010  
9000-07-1  Carrageenan, native  3  31, Sup 7  1987  
9000-38-8  Kava extract  2B  108  2016  
9002-84-0  Polytetrafluoroethylene  3  19, Sup 7  1987  
9002-86-2  Polyvinyl chloride  3  19, Sup 7  1987  
9002-88-4  Polyethylene  3  19, Sup 7  1987  
9002-89-5  Polyvinyl alcohol  3  19, Sup 7  1987  
9003-01-4  Polyacrylic acid  3  19, Sup 7  1987  
9003-07-0  Polypropylene  3  19, Sup 7  1987  
9003-20-7  Polyvinyl acetate  3  19, Sup 7  1987  
9003-22-9  Vinyl chloride-vinyl acetate copolymers  3  19, Sup 7  1987  
9003-39-8  Polyvinyl pyrrolidone  3  19, Sup 7, 71  1987  
9003-53-6  Polystyrene  3  19, Sup 7  1987  
9003-54-7  Styrene-acrylonitrile copolymers  3  19, Sup .7  1987  
9003-55-8  Styrene-butadiene copolymers  3  19, Sup 7  1987  
9004-51-7  Iron-dextrin complex  3  2, Sup 7  1987  
9004-66-4  Iron-dextran complex  2B  2, Sup 7  1987  
90045-36-6  Ginkgo biloba extract  2B  108  2016  
9009-54-5  Polyurethane foams  3  19, Sup 7  1987  
9010-98-4  Polychloroprene  3  19, Sup 7  1987  
9011-06-7  Vinylidene chloride-vinyl chloride copolymers  3  19, Sup 7  1987  
9011-14-7  Polymethyl methacrylate  3  19, Sup 7  1987  
9016-87-9  Polymethylene polyphenyl isocyanate  3  19, Sup 7  1987  
90370-29-9  4,4',6-Trimethylangelicin plus ultraviolet A radiation  3  Sup 7  1987  
91-20-3  Naphthalene  2B  82  2002  
91-22-5  Quinoline  2B  121  2019  
91-23-6  ortho-Nitroanisole  2A  65, 127  In prep.  NB Originally evaluated as 2-Nitroanisole
91-59-8  2-Naphthylamine  1  4, Sup 7, 99, 100F  2012  
91-64-5  Coumarin  3  Sup 7, 77  2000  
91-93-0  3,3'-Dimethoxybenzidine-4,4'-diisocyanate  3  39, Sup 7  1987  
91-94-1  3,3'-Dichlorobenzidine  2B  29, Sup 7  1987  
915-67-3  Amaranth  3  8, Sup 7  1987  
92-67-1  4-Aminobiphenyl  1  1, Sup 7, 99, 100F  2012  
92-87-5  Benzidine  1  29, Sup 7, 99, 100F  2012  
92-93-3  4-Nitrobiphenyl  3  4, Sup 7  1987  
924-16-3  N-Nitrosodi-n-butylamine  2B  17, Sup 7  1987  
924-42-5  N-Methylolacrylamide  3  60  1994  
93-15-2  Methyleugenol  2B  101  2013  
930-55-2  N-Nitrosopyrrolidine  2B  17, Sup 7  1987  
94-36-0  Benzoyl peroxide  3  36, Sup 7, 71  1999  
94-58-6  Dihydrosafrole  2B  10, Sup 7  1987  
94-59-7  Safrole  2B  10, Sup 7  1987  
94-75-7  2,4-D (2,4-dichlorophenoxyacetic acid) (See also Chlorophenoxy herbicides)  2B  113  2018  
95-06-7  Sulfallate  2B  30, Sup 7  1987  
95-50-1  ortho-Dichlorobenzene  3  Sup 7, 73  1999  
95-53-4  ortho-Toluidine  1  Sup 7, 77, 99, 100F  2012  
95-54-5  ortho-Phenylenediamine  2B  123  2020 online  
95-68-1  2,4-Xylidine  3  16, Sup 7  1987  
95-69-2  4-Chloro-ortho-toluidine  2A  77, 99  2010  
95-70-5  2,5-Diaminotoluene  3  16, Sup 7  1987  
95-78-3  2,5-Xylidine  3  16, Sup 7  1987  
95-79-4  5-Chloro-ortho-toluidine  3  77, 99  2010  
95-80-7  2,4-Diaminotoluene  2B  16, Sup 7  1987  
95-83-0  4-Chloro-ortho-phenylenediamine  2B  27, Sup 7  1987  
95-85-2  2-Amino-4-chlorophenol  2B  123  2020 online  
96-09-3  Styrene-7,8-oxide  2A  Sup 7, 60, 121  2019  NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
96-12-8  1,2-Dibromo-3-chloropropane  2B  20, Sup 7, 71  1999  
96-13-9  2,3-Dibromopropan-1-ol  2B  77  2000  
96-18-4  1,2,3-Trichloropropane  2A  63  1995  
96-23-1  1,3-Dichloro-2-propanol  2B  101  2013  
96-24-2  3-Monochloro-1,2-propanediol  2B  101  2013  
96-33-3  Methyl acrylate  2B  39, Sup 7, 71, 122  2019  
96-45-7  Ethylenethiourea  3  Sup 7, 79  2001  NB Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
96-48-0  gamma-Butyrolactone  3  11, Sup 7, 71  1999  
97-53-0  Eugenol  3  36, Sup 7  1987  
97-56-3  ortho-Aminoazotoluene  2B  8, Sup 7  1987  
97-77-8  Disulfiram  3  12, Sup 7  1987  
98-00-0  Furfuryl alcohol  2B  119  2019  
98-01-1  Furfural  3  63  1995  
98-56-6  4-Chlorobenzotrifluoride  2B  125  2020 online  
98-82-8  Cumene  2B  101  2013  
98-83-9  a-Methylstyrene  2B  101  2013  
98-87-3, 98-07-7, 100-44-7, 98-88-4  alpha-Chlorinated toluenes (benzal chloride, benzotrichloride, benzyl chloride) and benzoyl chloride (combined exposures)  2A  29, Sup 7, 71  1999  
98-95-3  Nitrobenzene  2B  65  1996  
989-38-8  Rhodamine 6G  3  16, Sup 7  1987  
99-08-1, 99-99-0  Nitrotoluenes  3  65  1996  
99-55-8  5-Nitro-ortho-toluidine  3  48  1990  
99-56-9  1,2-Diamino-4-nitrobenzene  3  16, Sup 7  1987  
99-57-0  2-Amino-4-nitrophenol  3  57  1993  
99-59-2  5-Nitro-ortho-anisidine  3  27, Sup 7  1987  
99-80-9  N-Methyl-N,4-dinitrosoaniline  3  1, Sup 7  1987  
99-97-8  N,N-Dimethyl-p-toluidine  2B  115  2018